OAM
GILD icon

Ostrum Asset Management’s Gilead Sciences GILD Stock Holding History

Ostrum Asset Management’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.1M Buy
8,670
+640
+8% +$84.3K 0.05% 217
2026
Q1 		$1.12M Sell
8,030
-18,466
-70% -$2.59M 0.06% 210
2025
Q4 		$3.25M Sell
26,496
-7,077
-21% -$860K 0.16% 99
2025
Q3 		$3.73M Buy
33,573
+5,099
+18% +$580K 0.17% 109
2025
Q2 		$3.16M Sell
28,474
-6,879
-19% -$732K 0.15% 127
2025
Q1 		$3.96M Sell
35,353
-777
-2% -$80.2K 0.21% 89
2024
Q4 		$3.34M Sell
36,130
-10,934
-23% -$984K 0.29% 89
2024
Q3 		$3.95M Sell
47,064
-17,275
-27% -$1.32M 0.33% 72
2024
Q2 		$4.41M Sell
64,339
-10,193
-14% -$680K 0.39% 53
2024
Q1 		$5.46M Sell
74,532
-1,326
-2% -$102K 0.43% 41
2023
Q4 		$6.15M Buy
75,858
+10,627
+16% +$827K 0.53% 31
2023
Q3 		$4.89M Sell
65,231
-12,679
-16% -$975K 0.45% 44
2023
Q2 		$6M Sell
77,910
-7,875
-9% -$628K 0.5% 36
2023
Q1 		$7.12M Buy
+85,785
New +$7.11M 0.62% 17
2019
Q1 		– Sell
-11,945
Closed -$747K – 148
2018
Q4 		$747K Buy
+11,945
New +$835K 0.29% 104

Other funds holding GILD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Ostrum Asset Management's GILD Position: Q2 2026 in Review

Ostrum Asset Management increased its Gilead Sciences (GILD) stake by 8% in Q2 2026, buying an estimated $84.3K and bringing the position to 8,670 shares worth $1.1M. The position accounts for 0.05% of the portfolio, ranked #217.

Ostrum Asset Management first reported a position in GILD in Q4 2018 and has held it in 15 quarters since. The position peaked at $7.12M in Q1 2023. 2,278 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Ostrum Asset Management held 8,670 shares of Gilead Sciences worth $1.1M as of Q2 2026.
  • Ostrum Asset Management bought 640 Gilead Sciences shares in Q2 2026, an estimated $84.3K.
  • Gilead Sciences made up 0.05% of Ostrum Asset Management's portfolio in Q2 2026, its #217 holding.
  • Ostrum Asset Management first reported a position in Gilead Sciences in Q4 2018 and has held it in 15 quarters since.
  • Ostrum Asset Management's Gilead Sciences position peaked at $7.12M in Q1 2023.
  • 2,278 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Ostrum Asset Management's 13F filing for Q2 2026, filed 13 Aug 2026.